Cargando…
Elevated Plasma Chemokines for Eosinophils in Neuromyelitis Optica Spectrum Disorders during Remission
BACKGROUND: A prominent pathological feature of neuromyelitis optica spectrum disorders (NMOSD) is markedly greater eosinophilic infiltration than that seen in other demyelinating diseases, like multiple sclerosis (MS). Eosinophils express the chemokine receptor CCR3, which is activated by eotaxins...
Autores principales: | Tong, Yanping, Yang, Tao, Wang, Jingwen, Zhao, Tianyou, Wang, Lei, Kang, Yuezhi, Cheng, Cuicui, Fan, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819570/ https://www.ncbi.nlm.nih.gov/pubmed/29497397 http://dx.doi.org/10.3389/fneur.2018.00044 |
Ejemplares similares
-
Association of Pain with Plasma C5a in Patients with Neuromyelitis Optica Spectrum Disorders During Remission
por: Tong, Yanping, et al.
Publicado: (2022) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica
por: Yang, Tao, et al.
Publicado: (2016) -
Elevated C‐X‐C motif ligand 13 and B‐cell‐activating factor levels in neuromyelitis optica during remission
por: Wang, Su, et al.
Publicado: (2017) -
Plasma exchange for acute optic neuritis in neuromyelitis optica or neuromyelitis optica spectrum disorder: a systematic review
por: Naphattalung, Yachinee, et al.
Publicado: (2023)